Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

26 Jun 2025 09:00

RNS Number : 5320O
Phoenix Group Holdings PLC
26 June 2025
 

LEI: 2138001P49OLAEU33T68

 

26 June 2025

 

 

Phoenix Group Holdings plc - Board Changes

 

The Board of Phoenix Group Holdings plc ("Phoenix" or the "Group") announces the following changes:

 

· Nicholas Shott, Group Independent Non-Executive Director and Chair of the Remuneration Committee, will be stepping down from the Board on 30 June 2025, having served nine years on the Board.

 

· Sherry Coutu CBE, Group Independent Non-Executive Director, will become Chair of the Remuneration Committee with effect from 1 July 2025, subject to regulatory approval and a member of the Group Board Nomination Committee on 1 July 2025.

 

 

Commenting on the changes, Sir Nicholas Lyons, Chair of Phoenix said:

 

"On behalf of the Board, I would like to thank Nicholas for his commitment and significant contribution to the Group during his tenure and I wish him every success for the future.

 

We look forward to welcoming Sherry as our new Remuneration Committee Chair. Her extensive FTSE 100 Remuneration Committee experience will prove invaluable."

 

 

 

This announcement is made pursuant to LR 6.4.6 and 6.4.8 of the Listing Rules. There is no further information required to be notified under Listing Rule 6.4.8 for Sherry Coutu CBE (over and above disclosed in the announcement made on 14 March 2025 appointing Sherry Coutu).

 

Enquiries:

Media

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors

Claire Hawkins, Director of Corporate Affairs & Brand, Phoenix Group+44 (0) 204 559 3161

Tom BlackwellManaging Director, FTI

+44 (0) 7747 113 919

 

Joanne Roberts, Investor Relations Director, Phoenix Group

+44 (0) 204 559 4673

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKABKOBKKFAB
Date   Source Headline
31st Jan 20222:00 pmRNSTotal Voting Rights
28th Jan 20227:09 amRNSStrategic Investor Update
18th Jan 20226:00 pmRNSHolding(s) in Company
18th Jan 20226:00 pmRNSHolding(s) in Company
17th Jan 20221:00 pmRNSDirector/PDMR Shareholding
14th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
11th Jan 20225:09 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
11th Jan 20227:00 amRNS2021 Bulk Purchase Annuity Transactions
7th Jan 20222:30 pmRNSDirector/PDMR Shareholding
31st Dec 202112:00 pmRNSTotal Voting Rights
30th Dec 20214:30 pmRNSDirector/PDMR Shareholding
22nd Dec 202112:00 pmRNSChange of Auditor
20th Dec 20211:00 pmRNSBlock listing Interim Review
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
30th Nov 20212:15 pmRNSTotal Voting Rights
9th Nov 202110:15 amRNSDirector/PDMR Shareholding
1st Nov 20214:52 pmRNSArk Life Assurance Sale Completion
29th Oct 20214:30 pmRNSTotal Voting Rights
8th Oct 20219:30 amRNSDirector/PDMR Shareholding
30th Sep 20215:00 pmRNSTotal Voting Rights
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
14th Sep 20212:07 pmRNSInternal Model Harmonisation Approval
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
1st Sep 202110:00 amRNSTotal Voting Rights
25th Aug 202112:00 pmRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
16th Aug 202112:00 pmRNSDirector/PDMR Shareholding
12th Aug 20214:00 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNS2021 Half Year Results
9th Aug 20214:30 pmRNSDirector/PDMR Shareholding
30th Jul 202111:45 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSSale of Ark Life Assurance Company
8th Jul 20214:20 pmRNSDirector/PDMR Shareholding
1st Jul 20214:00 pmRNSTotal Voting Rights
29th Jun 20214:15 pmRNSHolding(s) in Company
25th Jun 20214:00 pmRNSDirector/PDMR Shareholding
24th Jun 20215:15 pmRNSBlock listing Interim Review
23rd Jun 20215:30 pmRNSPhoenix Group Holdings
23rd Jun 20217:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
23rd Jun 20217:00 amRNSStrategic Investor Update and Board Change
22nd Jun 20214:40 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
16th Jun 20213:00 pmRNSBlock Listing Application
15th Jun 202112:00 pmRNSDiscussions in Respect of Sale Discontinued
9th Jun 20218:30 amRNSDirector/PDMR Shareholding
28th May 20212:00 pmRNSTotal Voting Rights
20th May 20214:00 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSStatement in Response to Press Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.